CytomX Therapeutics (CTMX) Retained Earnings (2014 - 2026)
CytomX Therapeutics (CTMX) posted Retained Earnings of $1.1 billion for Q1 2026, up 945879.28% on a QoQ basis from $111000.0 in Q4 2025, and up 51.5% year-over-year from $693.1 million in Q1 2025.
CytomX Therapeutics (CTMX) Retained Earnings (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Retained Earnings history runs 13 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- Quarterly Retained Earnings rose 51.5% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 51.5% YoY) and the FY2025 annual result came in at $111000.0, up 311.11% from the prior year.
- Retained Earnings was $1.1 billion for Q1 2026 at CytomX Therapeutics, up from $111000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $1.1 billion in Q1 2026 and bottomed at -$727.3 million in Q2 2023.
- A 5-year average of -$150.1 million and a median of -$63000.0 in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 263371.49% — and 2025, when it slumped 16705100.0%.
- CytomX Therapeutics' Retained Earnings stood at $637.1 million in 2022, then sank by 213.55% to -$723.4 million in 2023, then jumped by 100.0% to $27000.0 in 2024, then soared by 311.11% to $111000.0 in 2025, then surged by 945879.28% to $1.1 billion in 2026.
- Business Quant data shows CTMX's Retained Earnings at $1.1 billion in Q1 2026, $111000.0 in Q4 2025, and $104000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | 1.05 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 111,000.00 |
| Sep 30, 2025 | 104,000.00 |
| Jun 30, 2025 | -668.21 Mn |
| Mar 31, 2025 | 693.10 Mn |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | -710.46 Mn |
| Jun 30, 2024 | -4,000.00 |
| Mar 31, 2024 | 677.99 Mn |
| Dec 31, 2023 | -723.45 Mn |
| Sep 30, 2023 | -63,000.00 |
| Jun 30, 2023 | -727.28 Mn |
| Mar 31, 2023 | -726.19 Mn |
| Dec 31, 2022 | 637.12 Mn |
| Sep 30, 2022 | -714.10 Mn |
| Jun 30, 2022 | -685.04 Mn |
| Mar 31, 2022 | -655.54 Mn |
| Dec 31, 2021 | -242,000.00 |
| Sep 30, 2021 | -588.74 Mn |
| Jun 30, 2021 | -557.76 Mn |